Why CPS? In 2006, Rick Lamb, President, began building the CPS team with the goal to deliver cutting edge strategic publication plans. Rick brings 10 years of experience in creating effective publication teams and understands the demands for strategic, high-quality and timely publications from both the client and the agency viewpoints. With that in mind, he has gathered a team of experienced publication professionals whose goal is to produce strong publication plans for our clients.

CPS prides itself with an extensive publication planning knowledge and medical writing expertise that is shared with our publication planning partners. CPS is unique in that we have a proven publication process that ensures quality and scientific accuracy to meet current regulatory demands and public sensitivities. Equally, we are prepared to meet the internal operating procedures of our publication partners.

Scientific biomedical literature is still the key source for information for many physicians. The statement, "Science is real when it can be read," rings true today more than ever. So how does one keep abreast of the changing scientific biomedical literature landscape to optimally impact it?

At CPS, we have the ability to understand new issues and opportunities that face clients and service providers in developing effective publication strategies. Our forward thinking provides our clients with ways to respond and meet new and emerging regulations. All this will be performed in accordance with the standards set by the Good Publication Practice for Pharmaceutical Companies (GPP-PC) guidelines and the newly passed US Food and Drug Administration Amendments Act (FDAAA).

On April 2007, CPS became a division of MediMedia USA.
For more about CPS, see "Our Team".